Mutations in FTO and Dopamine Receptor Genes Increase Risk of Obesity and Diabetes
In the development of obesity and diabetes, signals from the brain play an important role. Here an important neurotransmitter is dopamine. DZD scientists from Tübingen and Munich, together with Swedish and American colleagues, have investigated how mutations in the obesity risk gene FTO and variants of the dopamine D2 receptor gene interact. Their results suggest that people in whom both genes are altered have a higher risk of developing obesity and diabetes. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)
Comments are closed.